These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28440002)

  • 1. Differential effect of Incobotulinumtoxin A on pain, neurogenic flare and hyperalgesia in human surrogate models of neurogenic pain.
    Diener SA; Breimhorst M; Vogt T; Krämer HH; Drummond PD; Geber C; Birklein F
    Eur J Pain; 2017 Sep; 21(8):1326-1335. PubMed ID: 28440002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
    Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
    Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.
    Tugnoli V; Capone JG; Eleopra R; Quatrale R; Sensi M; Gastaldo E; Tola MR; Geppetti P
    Pain; 2007 Jul; 130(1-2):76-83. PubMed ID: 17194546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization.
    Gazerani P; Staahl C; Drewes AM; Arendt-Nielsen L
    Pain; 2006 Jun; 122(3):315-325. PubMed ID: 16677761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychophysics, flare, and neurosecretory function in human pain models: capsaicin versus electrically evoked pain.
    Geber C; Fondel R; Krämer HH; Rolke R; Treede RD; Sommer C; Birklein F
    J Pain; 2007 Jun; 8(6):503-14. PubMed ID: 17434803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.
    Krämer HH; Angerer C; Erbguth F; Schmelz M; Birklein F
    J Neurol; 2003 Feb; 250(2):188-93. PubMed ID: 12574949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia.
    Baumann TK; Simone DA; Shain CN; LaMotte RH
    J Neurophysiol; 1991 Jul; 66(1):212-27. PubMed ID: 1919668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin.
    Sumikura H; Andersen OK; Drewes AM; Arendt-Nielsen L
    Pain; 2003 Sep; 105(1-2):285-91. PubMed ID: 14499446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.
    Voller B; Sycha T; Gustorff B; Schmetterer L; Lehr S; Eichler HG; Auff E; Schnider P
    Neurology; 2003 Oct; 61(7):940-4. PubMed ID: 14557564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal injection of Botulinum toxin type A alleviates infraorbital nerve constriction-induced thermal hyperalgesia in an operant assay.
    Kumada A; Matsuka Y; Spigelman I; Maruhama K; Yamamoto Y; Neubert JK; Nolan TA; Watanabe K; Maekawa K; Kamioka H; Yamashiro T; Kuboki T; Oguma K
    J Oral Rehabil; 2012 Jan; 39(1):63-72. PubMed ID: 21793870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flare and hyperalgesia after intradermal capsaicin injection in human skin.
    Serra J; Campero M; Ochoa J
    J Neurophysiol; 1998 Dec; 80(6):2801-10. PubMed ID: 9862885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The time course of brief and prolonged topical 8% capsaicin-induced desensitization in healthy volunteers evaluated by quantitative sensory testing and vasomotor imaging.
    Lo Vecchio S; Andersen HH; Arendt-Nielsen L
    Exp Brain Res; 2018 Aug; 236(8):2231-2244. PubMed ID: 29845449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model.
    Wallace MS; Quessy S; Schulteis G
    Pharmacol Biochem Behav; 2004 Jun; 78(2):349-55. PubMed ID: 15219777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial.
    Lam VY; Wallace M; Schulteis G
    J Pain; 2011 Mar; 12(3):323-30. PubMed ID: 20889387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.
    Blersch W; Schulte-Mattler WJ; Przywara S; May A; Bigalke H; Wohlfarth K
    J Neurol Sci; 2002 Dec; 205(1):59-63. PubMed ID: 12409185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenic hyperalgesia versus painful hypoalgesia: two distinct mechanisms of neuropathic pain.
    Baumgärtner U; Magerl W; Klein T; Hopf HC; Treede RD
    Pain; 2002 Mar; 96(1-2):141-51. PubMed ID: 11932070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction.
    Paterson K; Lolignier S; Wood JN; McMahon SB; Bennett DL
    Ann Neurol; 2014 Apr; 75(4):591-6. PubMed ID: 24550077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of High-Frequency Electrical Stimulation Following Sensitization With Capsaicin.
    Jutzeler CR; Curt A; Kramer JL
    J Pain; 2015 Jul; 16(7):595-605. PubMed ID: 25866256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models.
    Marinelli S; Luvisetto S; Cobianchi S; Makuch W; Obara I; Mezzaroma E; Caruso M; Straface E; Przewlocka B; Pavone F
    Neuroscience; 2010 Nov; 171(1):316-28. PubMed ID: 20826198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel therapeutic with two SNAP-25 inactivating proteases shows long-lasting anti-hyperalgesic activity in a rat model of neuropathic pain.
    Wang J; Casals-Diaz L; Zurawski T; Meng J; Moriarty O; Nealon J; Edupuganti OP; Dolly O
    Neuropharmacology; 2017 May; 118():223-232. PubMed ID: 28347837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.